Trinity has officially announced the broad launch of InsightsEDGE. Digital Twins, a market-tested AI solution designed to transform how life sciences organizations generate and use insights. With this innovation, the company introduces interactive virtual replicas of healthcare professionals (HCPs), patients, and payers, all grounded in real-world data and continuously evolving through advanced learning models.
Building on its existing InsightsEDGE platform, Trinity aims to eliminate the inefficiencies of fragmented, one-time insights. Instead, the new solution enables always-on customer understanding, allowing commercial teams to make faster and more precise decisions without the need to commission new research studies repeatedly. As a result, organizations can significantly improve agility in decision-making.
Moreover, Trinity has developed Digital Twins specifically for researchers, combining over 30 years of life sciences market research expertise with advanced AI and machine learning capabilities. These digital replicas are not static personas; rather, they are interactive, data-driven entities that can be engaged through natural language conversations using voice, text, or even generative video. Consequently, users gain deeper, more contextual insights tailored to specific therapeutic areas and business needs.
Unlike generic digital personas, Trinity ensures accuracy by calibrating and validating its Digital Twins against primary market research and real-world datasets. Therefore, the insights generated are highly precise and reflect real stakeholder behaviors and preferences.
At the core of this solution lies Weave, Trinity’s proprietary AI-powered unified data fabric. This system integrates multiple data sources, including primary research, prescription claims, EMR/EHR records, CRM systems, field feedback, and specialized datasets such as Trinity Digital Affinity. Importantly, the integration occurs at the individual (n=1) level, enabling highly personalized insights. Furthermore, Weave connects disparate data sources and scales insights across entire customer populations, creating a powerful and unified intelligence layer.
In addition, the platform operates as a closed-loop system. Every new analytics study, data update, or field interaction continuously feeds into the system, making Digital Twins smarter over time. As a result, insights, analytics, and field teams can collaborate using a single, dynamic source of truth.
“Biopharma companies invest millions in research, analytics, and field insights, but too often those assets end up trapped in decks and disconnected databases,” said Jonathan Jenkins, Head of Digital & AI Solutions, Trinity. “Trinity’s Digital Twins change that by unifying primary and secondary data at the individual customer level and making it usable in real time, so teams can hyper-personalize engagement, simulate real conversations in virtual environments, and make better decisions faster.”
Equally important, Trinity has prioritized security and compliance in the design of Digital Twins. The solution operates on an enterprise-grade governance framework, supports deployment within client firewalls, and enforces strict role-based access controls. Additionally, robust data sanitization measures help prevent exposure of personally identifiable information while safeguarding intellectual property. This ensures alignment with industry regulations, including privacy and pharmacovigilance requirements.
“Because our Digital Twins are grounded in Trinity research and compliant client data, they don’t just sound plausible, they reflect how real stakeholders think and behave,” said Amod Athavale, Executive Director, Head of Integrated Insights, Trinity. “With the safeguards, governance, and deployment options our clients expect from InsightsEDGE, they can trust the outputs, move faster, and make better commercial decisions at scale with confidence.”
Furthermore, Digital Twins address several critical challenges in the life sciences sector. For instance, organizations can conduct rapid, on-demand market research, test messaging and product concepts, and simulate real-world scenarios without launching new studies each time. In addition, field teams can enhance pre-call planning by anticipating customer responses and objections more effectively.
The solution also enables organizations to model the impact of market changes through “what-if” simulations, improving strategic planning. Whether used independently or alongside traditional research, Digital Twins provide richer and more validated insights.
Trinity offers multiple specialized Digital Twin applications, including Market Research, Patient, Payer, and HCP Digital Twins. Each serves a unique purpose, from refining value messaging and understanding patient behavior to analyzing prescribing patterns and competitive dynamics. Moreover, the solution seamlessly integrates with existing analytics platforms, CRM systems, and field tools, ensuring continuous intelligence across commercial operations.
Overall, with the global availability of InsightsEDGE | Digital Twins, Trinity is setting a new standard for AI-driven insights in the life sciences industry. By combining real data, continuous learning, and advanced AI capabilities, the company is enabling organizations to move faster, think smarter, and make more confident decisions in an increasingly complex healthcare landscape.
Recommended Cyber Technology News:
- Cobalt Adds Tony Spinelli to Board for Cybersecurity Growth
- Strobes Launches AI Harness for End-to-End Pen Testing
- Celerium Launches DIB CyberDome for Defense Cybersecurity
To participate in our interviews, please write to our CyberTech Media Room at info@intentamplify.com
